|
TMEM65 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.65689997464614E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.23579999858848E-08 |
| Normal-vs-Stage2 |
1.80820000084125E-08 |
| Normal-vs-Stage3 |
7.22449999823738E-09 |
| Normal-vs-Stage4 |
1.94759985916448E-10 |
| Stage1-vs-Stage2 |
1.850200E-01 |
| Stage1-vs-Stage3 |
4.871800E-01 |
| Stage1-vs-Stage4 |
1.280360E-02 |
| Stage2-vs-Stage3 |
4.918000E-01 |
| Stage2-vs-Stage4 |
3.275800E-01 |
| Stage3-vs-Stage4 |
6.672100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.15939999822956E-08 |
| Normal-vs-AfricanAmerican |
6.380300E-04 |
| Normal-vs-Asian |
1.67219999999135E-05 |
| Caucasian-vs-AfricanAmerican |
4.913800E-01 |
| Caucasian-vs-Asian |
6.057600E-01 |
| AfricanAmerican-vs-Asian |
8.073800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.55629994949658E-09 |
| Normal-vs-Female |
2.36310000456541E-08 |
| Male-vs-Female |
2.053400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.98669999954093E-07 |
| Normal-vs-Age(41-60Yrs) |
5.09419995076144E-09 |
| Normal-vs-Age(61-80Yrs) |
3.53300000366374E-09 |
| Normal-vs-Age(81-100Yrs) |
6.798100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.166000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.522200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.364600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.605800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.036000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.685600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.082350E-01 |
| Classical-VS-Follicular |
4.802400E-02 |
| Classical-VS-Other |
8.372400E-01 |
| Classical-VS-Normal |
2.5629000000027E-07 |
| Tall-VS-Follicular |
7.477400E-01 |
| Tall-VS-Other |
5.759800E-01 |
| Tall-VS-Normal |
1.66319999994613E-07 |
| Follicular-VS-Other |
6.613000E-01 |
| Follicular-VS-Normal |
7.14990000538762E-09 |
| Other-VS-Normal |
2.710000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.22609999720203E-09 |
| Normal-vs-N1 |
9.24659999679278E-08 |
| N0-vs-N1 |
6.952200E-01 |
|
|
